Companies / Eli Lilly and Company
Eli Lilly and Company
Company- Registered trials
- 2878
- Ongoing
- 378/ 13%
- Completed
- 2194
- Related drugs
- 18
- Related conditions
- 27
Clinical trial landscape
2878 registered studies reference this company or one of its brands. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Phase 1 | 872 | 75 | 733 | |
| Phase 2 | 694 | 103 | 487 | |
| Phase 3 | 667 | 101 | 515 | |
| Phase 4 | 284 | 25 | 237 | |
| Unknown | 136 | 34 | 76 | |
| Phase 1/2 | 93 | 21 | 52 | |
| Not applicable | 85 | 13 | 60 | |
| Phase 2/3 | 40 | 5 | 30 | |
| Early Phase 1 | 7 | 1 | 4 | |
| All phases | 2878 | 378 | 2194 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Recent developments
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.